SEC Tracker
Get the app

ENDRA Life Sciences NDRA

Anthony DiGiandomenico updates its stake in ENDRA Life Sciences to 9.9%

Form
Schedule 13D/A
Filed
Importance
Notable

Not explained yet; the original is on EDGAR.

Ownership stake disclosure by Anthony Digiandomenico (amended)

View on EDGAR

Open in the app

Get an email when ENDRA Life Sciences files

Only major filings: results, leadership changes, listing notices and other major events, each with the plain-English summary when we have one or the key facts and the EDGAR link. Routine insider filings never email. Confirm once; unsubscribe in one click.

Similar companies

Companies of similar size in SIC 3845 and related industry codes: the same peer list as the financial tables.

  1. Global Innovative Platforms GIPL public float $3M, Sep 30, 2025
  2. Interpace Biosciences IDXG public float $3M, Jun 30, 2025
  3. Bluejay Diagnostics BJDX public float $3M, Jun 30, 2025
  4. Stimcell Energetics STME public float $2M, Nov 30, 2025
  5. LogicMark LGMK public float $2M, Jun 30, 2025